Rain Therapeutics Inc.

Rain Therapeutics Inc.verified

RAIN

Price:

$1.21

Market Cap:

$44.01M

Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II clinical trial for solid tumors, and Phase II clinical trial for intimal sarcoma, as well as RAD52 which is in preclinical trials for tumors, including breast, ovarian, pancreatic, prostate, and other cancers. Rain Therapeutics Inc. was incorporated in 2017 and is headquartered in Newark, California.[Read more]

Industry

Biotechnology

IPO Date

2021-04-23

Stock Exchange

NASDAQ

Ticker

RAIN

The Current Ratio as of December 2024 (TTM) for Rain Therapeutics Inc. (RAIN) is 5.58

According to Rain Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.58. This represents a change of -0.44% compared to the average of 5.61 of the last 4 quarters.

Rain Therapeutics Inc. (RAIN) Historical Current Ratio (quarterly & annually)

How has RAIN Current Ratio performed in the past?

The mean historical Current Ratio of Rain Therapeutics Inc. over the last ten years is 9.39. The current 5.58 Current Ratio has changed 5.84% with respect to the historical average. Over the past ten years (40 quarters), RAIN's Current Ratio was at its highest in in the June 2021 quarter at 18.56. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

9.39

Median

7.52

Minimum

5.13

Maximum

17.41

Rain Therapeutics Inc. (RAIN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Rain Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 239.65%

Maximum Annual Current Ratio = 17.41

Minimum Annual Increase = -48.55%

Minimum Annual Current Ratio = 5.13

Quarterly (TTM)
Annual
YearCurrent RatioChange
20226.08-32.09%
20218.96-48.55%
202017.41239.65%

Rain Therapeutics Inc. (RAIN) Average Current Ratio

How has RAIN Current Ratio performed in the past?

The current Current Ratio of Rain Therapeutics Inc. (RAIN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

10.82

5-year avg

9.39

10-year avg

9.39

Rain Therapeutics Inc. (RAIN) Current Ratio vs. Peers

How is RAIN’s Current Ratio compared to its peers?

Rain Therapeutics Inc.’s Current Ratio is less than AVROBIO, Inc. (26.17), less than CohBar, Inc. (15.69), greater than Ocean Biomedical, Inc. (0.07), greater than Enveric Biosciences, Inc. (5.17), less than Elevation Oncology, Inc. (17.77), greater than Hepion Pharmaceuticals, Inc. (1.30), less than Zura Bio Limited (10.36), greater than eFFECTOR Therapeutics, Inc. (1.03),

Build a custom stock screener for Rain Therapeutics Inc. (RAIN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rain Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rain Therapeutics Inc. (RAIN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rain Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Rain Therapeutics Inc.'s Current Ratio?

How is the Current Ratio calculated for Rain Therapeutics Inc. (RAIN)?

What is the highest Current Ratio for Rain Therapeutics Inc. (RAIN)?

What is the 3-year average Current Ratio for Rain Therapeutics Inc. (RAIN)?

What is the 5-year average Current Ratio for Rain Therapeutics Inc. (RAIN)?

How does the current Current Ratio for Rain Therapeutics Inc. (RAIN) compare to its historical average?